Comments
GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that a meeting of the Board of Directors will be held on November 01, 2018, inter alia, to consider and take on record the Unaudited Financial Results for the Second Quarter ended September 30, 2018 with Limited Review by Auditors (Q2).
Pdf Link: Glaxosmithkline Consumer Healthcare Ltd. - Q2 results on Nov 01, 2018
Source : BSE - www.bseindia.com
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.